Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
tags : Bioscience crawled time : 13:30 save search
Yield10 Bioscience Reports that Proprietary Varieties of Winter Camelina Show Tolerance to Commonly Used Herbicides in First Field Tests
Published: 2024-02-29 (Crawled : 13:30) - globenewswire.com
YTEN | $0.267 4.71% 4.49% 380K
|
Health Technology
|
| O: -9.49%
H: 8.32%
C: 2.47%
first bioscience show
Twist Bioscience Corporation Announces Inducement Grants under NASDAQ Listing Rule 5635(c)(4) - February 7, 2024
Published: 2024-02-07 (Crawled : 13:30) - biospace.com/
TWST | $29.49 5.51% 5.22% 940K
|
Health Technology
|
| O: -1.08%
H: 1.07%
C: -4.38%
nasdaq corporation bioscience grants
Twist Bioscience Reports Fiscal First Quarter 2024 Financial Results
Published: 2024-02-02 (Crawled : 13:30) - biospace.com/
TWST | $29.49 5.51% 5.22% 940K
|
Health Technology
|
| O: 14.25%
H: 0.11%
C: -3.71%
first bioscience financial results
Lexaria Bioscience Corp. (NASDAQ: LEXX) Proprietary Drug-Delivery System Improves Way Molecules Enter Bloodstream
Published: 2024-01-11 (Crawled : 13:30) - globenewswire.com
LEXX | $2.2 0.88% 34K
|
Health Technology
|
| O: 0.69%
H: 5.52%
C: 4.83%
bioscience system bloodstream
Lexaria Bioscience Corp. (NASDAQ: LEXX) Improves Delivery, Efficacy of GLP-1 Agonists Through Proprietary Drug-Delivery Platform
Published: 2024-01-09 (Crawled : 13:30) - globenewswire.com
LEXX | $2.2 0.88% 34K
|
Health Technology
|
| O: 0.73%
H: 4.86%
C: 2.9%
bioscience platform
Yield10 Bioscience to Announce Third Quarter 2023 Financial Results and Host a Conference Call on Tuesday, November 14, 2023
Published: 2023-11-08 (Crawled : 13:30) - globenewswire.com
YTEN | $0.267 4.71% 4.49% 380K
|
Health Technology
|
| O: -0.71%
H: 3.78%
C: -10.07%
conference bioscience financial results
Bayer to Partner With Twist Bioscience to Accelerate Drug Discovery
Published: 2023-10-05 (Crawled : 13:30) - biospace.com/
TWST | $29.49 5.51% 5.22% 940K
|
Health Technology
|
| O: 6.74%
H: 0.25%
C: -5.91%
drug bioscience
Twist Bioscience Enters into Antibody Discovery and Licensing Option Agreement with Bayer of up to $188 Million
Published: 2023-10-05 (Crawled : 13:30) - biospace.com/
TWST | $29.49 5.51% 5.22% 940K
|
Health Technology
|
| O: 6.74%
H: 0.25%
C: -5.91%
antibody bioscience agreement
Twist Bioscience Appoints Mark Buck as Senior Vice President, Operations
Published: 2023-10-03 (Crawled : 13:30) - biospace.com/
TWST | $29.49 5.51% 5.22% 940K
|
Health Technology
|
| O: -0.99%
H: 2.27%
C: -3.21%
bioscience
Agilent Technologies and Exact Sciences Agree to Terms of Sale for Resolution Bioscience
Published: 2023-09-12 (Crawled : 13:30) - biospace.com/
A | $133.91 0.89% 0.0% 850K
|
Health Technology
|
| O: 0.27%
H: 0.5%
C: -0.55%
EXAS | $62.41 2.38% 2.32% 1.6M
|
Health Technology
|
| O: -0.44%
H: 1.44%
C: -1.05%
bioscience sciences
Cannabis Bioscience International Holdings (CBIH) Unveils Its Rebranding Through Its New and Innovative Website
Published: 2023-09-11 (Crawled : 13:30) - globenewswire.com
CBIH | $0.0006 -62.5% 600K
|
Mining, Quarrying, and Oil and ...
|
| O: -12.5%
H: 14.29%
C: 14.29%
cannabis bioscience international
Satellos Bioscience Announces Q2 2023 Financial Results and Operational Highlights
Published: 2023-08-29 (Crawled : 13:30) - biospace.com/
SNY | News | $47.125 1.78% 1.75% 2.1M
|
Health Technology
|
| O: 0.34%
H: 0.0%
C: 0.0%
bioscience financial results
INVO Bioscience to Exhibit at the 2022 Pacific Coast Reproductive Society (PCRS) Annual Meeting
Published: 2022-03-24 (Crawled : 13:30) - invobioscience.com
INVO | $1.24 -9.49% -10.48% 910K
|
Health Technology
|
| O: -4.15%
H: 4.33%
C: 3.74%
bioscience
Revelation Biosciences Inc. Announces Enrollment and Dosing Complete for Phase 2b Viral Challenge Study to Assess Efficacy of Intranasal REVTx 99 for the Prevention of H3N2 Influenza Infection
Published: 2022-03-15 (Crawled : 13:30) - biospace.com/
REVB | $2.05 -8.48% -9.27% 22K
|
|
| O: 9.8%
H: 63.39%
C: 11.61%
phase 2 phase 2b bioscience infection influenza enroll infections
Junshi Biosciences and Coherus Announce Presentation of Positive Results from CHOICE-01, a Phase 3 Clinical Trial Evaluating Toripalimab in Combination with Chemotherapy as First-Line Treatment for Non-Small Cell Lung Cancer, at March ASCO Plenary Series
Published: 2022-03-15 (Crawled : 13:30) - globenewswire.com
CHRS | $2.19 5.8% 5.48% 1.5M
|
Health Technology
|
| O: 1.41%
H: 5.81%
C: 2.53%
hoice-01 treatment pos trial presentation cel positive results asco lung cancer positive therapy bioscience results cancer phase 3
Liminal BioSciences Provides Update on Its Lead Drug Candidate Fezagepras
Published: 2022-03-14 (Crawled : 13:30) - biospace.com/
LMNL | $8.5 0.12% 0.12% 0
|
Health Technology
|
| O: 1.08%
H: 1.31%
C: -2.32%
drug bioscience
HARMONY BIOSCIENCES TO PARTICIPATE IN TWO INVESTOR CONFERENCES IN MARCH
Published: 2022-03-09 (Crawled : 13:30) - prnewswire.com
HRMY | $29.39 -0.03% -0.03% 300K
|
Health Technology
|
| O: 4.19%
H: 3.46%
C: 2.39%
conference bioscience
Artelo Biosciences Receives Notice of Allowance for Method-of-Use Patent in the United States for ART12.11, a Proprietary Cocrystal of Cannabidiol
Published: 2022-03-02 (Crawled : 13:30) - globenewswire.com
ARTL | News | $1.34 1.9% 1.87% 3.6K
|
Health Technology
|
| O: 6.33%
H: 11.62%
C: 7.5%
art12 state patent bioscience
Yield10 Bioscience to Announce Fourth Quarter and Full Year 2021 Financial Results and Host a Conference Call on Wednesday, March 9, 2022
Published: 2022-03-02 (Crawled : 13:30) - globenewswire.com
YTEN | $0.267 4.71% 4.49% 380K
|
Health Technology
|
| O: -6.19%
H: 7.09%
C: 5.13%
day financial results conference bioscience results
Prometheus Biosciences to Participate at the Cowen 42nd Annual Healthcare Conference
Published: 2022-03-01 (Crawled : 13:30) - globenewswire.com
RXDX | $199.92 0.02% 1.9M
|
Professional, Scientific, and T...
|
| O: 1.05%
H: 6.13%
C: -0.39%
health thc conference bioscience
Gainers vs Losers
| 75% | 25% |
Top 10 Gainers
MTTR | News M | $4.78 174.71% 63.6% 72M
|
AGBA | $2.565 105.2% 51.27% 200M
|
Finance
MLEC | $2.44 74.29% 42.62% 78M
|
n/a
EDBL | News | $6.28 67.02% 40.13% 16M
|
ATGL | $2.91 48.81% 32.8% 180K
|
ZAPP | $0.2175 47.16% 32.05% 16M
|
n/a
ONFO | $0.6075 38.38% 27.74% 7.3M
|
n/a
VIVK | $1.48 38.32% 27.7% 530K
|
Professional, Scientific, and T...
MNTS | $0.5 35.69% 26.3% 4.8M
|
SDIG A | $3.635 35.13% 26.0% 1M
|
Your saved searches
Save your searches and get alerts when important news are released.